A randomized, double-blind, placebo and moxifloxacin (open-label) controlled, 4-period, crossover study of the effects of multiple oral doses of ERB-041 [prinaberel] on cardiac repolarization in healthy subjects
Phase of Trial: Phase I
Latest Information Update: 12 Apr 2007
At a glance
- Drugs Prinaberel (Primary)
- Indications Endometriosis; Rheumatoid arthritis
- Focus Pharmacodynamics
- 22 Nov 2006 New trial record.